Topical Pharmacokinetics of Brinzolamide Suspensions in Rabbits and Variability Analysis for Sample Size and Design Considerations.

[1]  C. Strachan,et al.  Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin , 2021, Pharmaceutics.

[2]  Jiwen Zheng,et al.  Analyzing Ophthalmic Suspension Particle Size Distributions Using Laser Diffraction: Placebo Background Subtraction Method. , 2021, International journal of pharmaceutics.

[3]  Jiwen Zheng,et al.  In Vitro Physicochemical Characterization and Dissolution of Brinzolamide Ophthalmic Suspensions with Similar Composition. , 2020, International journal of pharmaceutics.

[4]  A. Urtti,et al.  Comprehensive ocular and systemic pharmacokinetics of brinzolamide in rabbits after intracameral, topical, and intravenous administration. , 2020, Journal of pharmaceutical sciences.

[5]  M. Jamei,et al.  Ocular intracameral pharmacokinetics for a cocktail of timolol, betaxolol and atenolol in rabbits. , 2019, Molecular pharmaceutics.

[6]  E. Stefánsson,et al.  Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye. , 2007, Acta ophthalmologica Scandinavica.

[7]  T. Kaila,et al.  Absorption of ocular timolol: drug concentrations and ß‐receptor binding activity in the aqueous humour of the treated and contralateral eye , 1993, Acta ophthalmologica.

[8]  R. Huupponen,et al.  The pharmacokinetics of ocularly applied timolol in rabbits , 1987, Acta ophthalmologica.

[9]  P. Stewart,et al.  Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. , 1980, Journal of pharmaceutical sciences.

[10]  J. Robinson,et al.  Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone. , 1975, Journal of pharmaceutical sciences.

[11]  R. Dengler,et al.  Ocular absorption of dexamethasone phosphate disodium by the rabbit. , 1967, Archives of ophthalmology.

[12]  D. Kozak,et al.  Approval of Topical Ophthalmic Generic Products in the USA: Simple to Complex Dosage Forms and Establishing Equivalency , 2021, Ophthalmic Product Development.